Innovation Works

Innovation Works is proud to collaborate with NVIDIA in launching Pittsburgh’s inaugural AI Tech Community — a groundbreaking initiative to drive AI innovation through collaboration across academia, industry, and the public sector. "At Innovation Works, we believe in the power of collaboration and strategic partnerships to unlock the next wave of innovative technology and empower local entrepreneurs.?Through this partnership, the region will have access to the tools and resources necessary to accelerate AI innovation. We are proud to be involved in such a cutting-edge initiative." - Ven Raju With partnerships at Carnegie Mellon University and the University of Pittsburgh, NVIDIA’s initiative will establish two joint technology centers to advance AI applications in robotics, health sciences, and more. Leveraging NVIDIA’s advanced AI platforms, these centers will empower local talent to lead the way in research and technology. Alongside support from AlphaLab, the Robotics Factory, and the Pittsburgh Robotics Network, this initiative strengthens Pittsburgh’s role as a key player in the global AI landscape. Read the official release here https://lnkd.in/ePMZm-vd

Thank you to the The Wall Street Journal for recently featuring President & CEO Ven Raju in their?VC Daily newsletter: "Founder involvement at the ground level can be crucial in the early stages of a company. Their passion and vision help set the tone and culture, helping to drive the most critical breakthroughs. However, as a company scales, there's a point where founder micromanagement can impede growth. The most successful founders learn to build a strong team of functional and domain experts and in turn trust their team to help drive growth and scale." #Leadership #Innovation #Startups #VentureCapital Read the full newsletter here: https://bit.ly/4dvZqCZ

Congratulations to #ALHAlum company CytoAgents, Inc on being awarded a $2 million The National Institutes of Health grant! This is their third NIH grant in four years, a true testament to the impact of their groundbreaking work in addressing Cytokine Release Syndrome (CRS) for patients undergoing CAR T-Cell therapy. This funding will accelerate the development of their lead drug candidate, CTO1681, and bring much-needed innovation to an area of critical unmet medical need. We’re excited to see CytoAgents continue to push the boundaries of scientific discovery and improve patient outcomes. https://lnkd.in/eU-7GFT8

Don't miss the AI Horizons Pittsburgh Summit on October 14! Meredith Meyer Grelli will be moderating a panel, "Disrupting the Startup: How AI will Democratize Entrepreneurship and Shift the VC Landscape." Find out more about the panel https://lnkd.in/enCMJG_v The Summit will explore the transformative potential of AI for societal good in a city globally renowned for its humility, grit and technological leadership, alongside pioneers in the field.?Register for the Summit here https://aihorizonspgh.com/

A big thank you to Thiopoly for presenting at the 2024 AI & Robotics Venture Fair! We appreciate Douglas Descalzi for sharing valuable insights into the growing challenges in medication management and how sensing, digital visibility, and AI are shaping the future of healthcare.

Learn how three unique Pennsylania companies are changing the future. All three presented at AI & Robotics Fair, a seven year event that is unique to Pittsburgh. Details here. https://lnkd.in/e-W7yUFV Carnegie Mellon University - Tepper School of Business Innovation Works Jordan Marinkovich, MBA Jane K Joseph Ven Raju Kirk Botula Dave Mawhinney Bruce Kraselsky Joe Mullenbach Clark Haynes NEXTpittsburgh Cristina Holtzer velo.ai Fluid Reality X-Hab 3D Confirmed Josh Lucas Suzy Teele Sreekar Gadde

The application window for this year’s 3 Rivers Venture Fair closes Wednesday. Don’t miss your next big funding opportunity. Apply today at 3RVF.com/apply.

We are excited to join you at the Spatial Biology Europe Congress (Omics by Oxford Global) in #Basel as Gold Sponsors, revolutionizing this dynamic field together. At PredxBio, we are at the forefront of innovation, using spatial multi-omics and cutting-edge spatial computing to unlock the complexities of the tumor microenvironment using #actionable AI-driven Spatial Biomarkers. At this event, September 30- October 1 in Basel, our CEO, Dusty Majumdar, PhD, will showcase our groundbreaking #SpaceIQ? platform, revealing how we leverage AI-driven spatial biomarkers to uncover new mechanisms of cancer. Our VP of Research, Filippo Pullara, PhD, will also participate in a panel discussion, sharing insights on how we empower Pharma companies to increase the success rates of definitive clinical trials. Don’t miss out on their incredible sessions: Monday, September 30 (Day 1), Conference Room #5 ?? 11:05 am: Dusty Majumdar, PhD, CEO, ?? 2:35 pm: Filippo Pullara, PhD, VP of Research Be sure to visit us at the Spatial Biology Europe Congress in Basel at?Booth #2?for an immersive demo of SpaceIQ? using Apple Vision Pro and discover how we’re accelerating innovation in oncology.?Explore our 20+ peer-reviewed clinical proof publications in top journals, https://lnkd.in/guRMibd6 #OGOmics #SpatialBiologyEU24 #spatialbiology #explainableai #aibiomarkers #biomarkers #spatialanalysis #immunooncology #cancerresearch #innovation #clinicaloncology #ai #xai Oxford Global Dusty Majumdar, PhD, S. Chakra Chennubhotla, Craig Cinquina, Filippo Pullara, Akif Burak Tosun, Brian Falkenstein, Goran Pljevaljcic, Shannon Quinn, Sam Hanash, Innovation Works, Christian Seeney, Luke Kaymak, Déborah Heintze, Michele Sperandio, Siddika Demir, Marcel Gatti, Jeff Cohen

Yesterday's 7th annual AI & Robotics Venture Fair, presented by Innovation Works and Carnegie Mellon University, was an incredible showcase of cutting-edge technology! From AI-powered solutions to autonomous robotics, 18 innovative companies shared their groundbreaking advancements that are shaping the future of multiple industries. A huge thank you to all the amazing presenters and attendees who made this event such a success! We're excited to see how these ventures continue to push the boundaries of what's possible in AI and robotics.